Subject
Pharmaceutical Science,Pharmacology
Reference34 articles.
1. Multiple weekly dalbavancin dosing for the treatment of native vertebral osteomyelitis caused by methicillin-resistant staphylococcus aureus: a case report;Almangour;Am. J. Case Rep.,2017
2. Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility;Almangour;Diagn. Microbiol. Infect. Dis.,2019
3. New antibiotics for bad bugs: where are we?;Bassetti;Ann. Clin. Microbiol. Antimicrobials,2013
4. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam;Breedt;Antimicrob. Agents Chemother.,2005
5. Corey, G.R., Wilcox, M.H., Talbot, G.H., Thye, D., Friedland, D., Baculik, T., 2010. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J. Antimicrob. Chemother., 65 Suppl 4, iv41-51. doi:10.1093/jac/dkq254